Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

ADVMADVM
10 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in ADVERUM BIOTECHNOLOGIES INC

WELLS FARGO & COMPANY/MN previously held 0 shares of ADVM (ADVERUM BIOTECHNOLOGIES INC), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$2,912

Total Shares Change

-1,941

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$4.60
0
2025-Q3
Decreased
30
-86.0%
$1360.0%$4.60
0
2025-Q2
Decreased
214
-98.3%
$4610.0%$2.32
0
2025-Q1
Increased
12,531
+2.4%
$54,7610.0%$4.61
14
2024-Q4
Increased
12,240
+27.8%
$57,1610.0%$4.69
18
2024-Q3
Increased
9,581
+4.8%
$67,2590.0%$6.94
15
2024-Q2
Increased
9,140
+6336.6%
$62,7000.0%$6.86
23
2024-Q1
Decreased
142
-85.5%
$2,0080.0%$14.14
0
2023-Q4
Decreased
976
-49.7%
$7350.0%$7.53
0
2023-Q3
New
1,941
-
$2,9120.0%$15.00
20

Other major holders of ADVM: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used